%0 Journal Article %A Sizheng Steven Zhao %A Michael V Holmes %A Jie Zheng %A Eleanor Sanderson %A Alice R Carter %T The impact of education inequality on rheumatoid arthritis risk is mediated by smoking and body mass index: mendelian randomization study %D 2021 %R 10.1101/2021.04.20.21254536 %J medRxiv %P 2021.04.20.21254536 %X Objective To estimate the causal relationship between educational attainment – as a proxy for socioeconomic inequality – and risk of RA and quantify the roles of cigarette smoking and body mass index (BMI) as potential mediators.Methods Using the largest genome-wide association studies (GWAS), we performed a two-sample Mendelian randomization (MR) study of genetically predicted educational attainment (instrumented using 1265 variants from 766,345 individuals) and RA (14,361 cases, 43,923 controls). We used two-step MR to quantify the proportion of education’s effect on RA mediated by smoking exposure (as a composite index capturing duration, heaviness and cessation, using 124 variants from 462,690 individuals) and BMI (517 variants, 681,275 individuals), and multivariable MR to estimate proportion mediated by both factors combined.Results Each standard deviation (SD) increase in educational attainment (4.2 years of schooling) was protective of RA (OR 0.37; 95%CI 0.31, 0.44). Higher educational attainment was also protective for smoking exposure (β= -0.25 SD; 95%CI -0.26, -0.23) and BMI (β= -0.27 SD (∼1.3kg/m2); 95%CI -0.31, - 0.24). Smoking mediated 24% (95%CI 13%, 35%) and BMI 17% (95%CI 11%, 23%) of the total effect of education on RA. Combined, the two risk factors explained 47% (95%CI 11%, 82%) of the total effect.Conclusion Higher educational attainment has a protective effect on RA risk. Interventions to reduce smoking and excess adiposity at a population level may reduce this risk, but a large proportion of education’s effect on RA remains unexplained. Further research into other risk factors that act as potentially modifiable mediators are required.Key messagesGenetically predicted higher educational attainment – as a proxy for socioeconomic position – is protective for RA.24% of this effect was mediated by smoking behaviour and 17% by body mass index.Efforts to reduce smoking and excess adiposity would help mitigate against socioeconomic inequalities in RACompeting Interest StatementThe authors have declared no competing interest.Funding StatementES and ARC work in a unit that receives core funding from the UK Medical Research Council and University of Bristol (MC_UU_00011/1 and MC_UU_00011/6). JZ is supported by the UK Medical Research Council Integrative Epidemiology Unit (MC_UU_00011/1 and MC_UU_00011/4). Jie Zheng is supported by the Academy of Medical Sciences (AMS) Springboard Award, the Wellcome Trust, the Government Department of Business, Energy and Industrial Strategy (BEIS), the British Heart Foundation and Diabetes UK (SBF006\1117). JZ is funded by the Vice-Chancellor Fellowship from the University of Bristol. MVH works in a unit that receives funding from the UK Medical Research Council and is supported by a British Heart Foundation Intermediate Clinical Research Fellowship (FS/18/23/33512) and the National Institute for Health Research Oxford Biomedical Research Centre.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Participating studies of respective GWAS meta-analyses have received prior approval by relevant institutional review boards, and informed consent was obtained from each study participant (details in Table 1). The current study used publicly available summary statistics data; therefore, no additional ethics approval was required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSummary statistics are available from each consortia (details in Table 1) or via the MR-Base platform (https://gwas.mrcieu.ac.uk/). %U https://www.medrxiv.org/content/medrxiv/early/2021/04/22/2021.04.20.21254536.full.pdf